ArticleBMC gastroenterology2022

Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn's disease.

Hisashi Hirayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.